Dec. 5, 2019—Poorly functioning AMPARs have been linked to a wide range of neurological and psychiatric disorders including seizures, Alzheimer’s disease, major depression and autism spectrum disorder. Understanding how AMPARs are formed and operate is essential for the rational design of pharmacological compounds that, by tuning AMPAR activity up or down, could improve treatment of these conditions.
May. 1, 2019—Two giants in the science world joined Chancellor Nicholas S. Zeppos onstage Tuesday for the academic year’s final Chancellor’s Lecture Series event, passionately advocating for an America that encourages its citizens to abandon simple opinion on big challenges and instead use evidence-based, critical thinking.
Apr. 22, 2019—Science advocacy and innovation will be the theme of the final Chancellor’s Lecture of the 2018-19 season, set for Tuesday, April 30, in Langford Auditorium. Chancellor Nicholas S. Zeppos will host Mae Jemison and Rush Holt, two scientists with storied careers in government and public service.
Feb. 23, 2017—DNA replication is an extraordinarily complex multi-step process that makes copies of the body’s genetic blueprint. It is necessary for growth and essential to life. Now researchers at the California Institute of Technology (Caltech) and Vanderbilt University have found evidence that one of those steps may involve the telephone-like transmission of electrical signals regulated by a chemical “switch.”
Sep. 16, 2016—New ethical rules for scientists who do experiments involving human beings are about to kick in. It's the first update in more than 40 years.
Sep. 8, 2016—A multi-center research team including scientists from the Vanderbilt Vaccine Center has come up with a clever “Trojan Horse” strategy for thwarting the highly lethal Ebola virus.
Aug. 11, 2016—Terunaga Nakagawa, with colleagues from Japan and Oxford University in England, has discovered the bridgelike molecular structure of a mysterious glutamate receptor.
Jul. 9, 2015—Researchers at Vanderbilt University and the National University of Singapore have determined the structure of a human monoclonal antibody which, in an animal model, strongly neutralizes a type of the potentially lethal dengue virus.